Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
暂无分享,去创建一个
S. Young | E. Sternberg | I. Magnussen | M. V. Van Woert | C. K. Osterland | H. Baker | S. Gauthier | C. Osterland
[1] T. Magnusson,et al. A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from the same tissue sample using a single column of strongly acidic cation exchange resin. , 2009, Acta pharmacologica et toxicologica.
[2] A. Brenner,et al. A pyridoxine-dependent behavioral disorder unmasked by isoniazid. , 1978, American journal of diseases of children.
[3] R. Wurtman,et al. Effect of pyridoxine on the depletion of tissue pyridoxal phosphate by carbidopa. , 1978, Metabolism: clinical and experimental.
[4] I. Magnussen,et al. Determination of 5-hydroxytryptophan in plasma by high-performance liquid chromatography and fluorometric detection after phthaldialdehyde reaction. , 1978, Clinical chemistry.
[5] S. Jabłońska,et al. 5‐Hydroxytryptamine and tryptamine pathways in scleroderma , 1977, The British journal of dermatology.
[6] M. Bowers,et al. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. , 1977, The New England journal of medicine.
[7] M. H. Joseph,et al. The determination of kynurenine in plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.
[8] N. Keiding. Phosphatase Isoenzymes in Human Serum , 1974 .
[9] E. Reynolds. Anticonvulsants, folic acid, and epilepsy. , 1973, Lancet.
[10] J. Fries,et al. Scleroderma-like lesions and the carcinoid syndrome. , 1973, Archives of internal medicine.
[11] P. Calandra,et al. Tryptophan → niacin pathway in scleroderma and in dermatomyositis , 1973, Archiv für dermatologische Forschung.
[12] B. Gibbs,et al. A rapid method for the analysis of urinary methylmalonic acid. , 1972, Clinica chimica acta; international journal of clinical chemistry.
[13] G. Curzon,et al. Rapid method for the determination of 5‐hydroxytryptamine and 5‐hydroxyindoleacetic acid in small regions of rat brain , 1970, British journal of pharmacology.
[14] J. Graham. CARDIAC AND PULMONARY FIBROSIS DURING METHYSERGIDE THERAPY FOR HEADACHE , 1967, The American journal of the medical sciences.
[15] C. M. Leevy,et al. A protozoological method for detecting clinical vitamin B6 deficiency. , 1966, American Journal of Clinical Nutrition.
[16] R. A. Green,et al. Rheumatic symptoms during tuberculosis therapy. A manifestation of isoniazid toxicity? , 1965, Annals of internal medicine.
[17] S. Lorber,et al. ASSOCIATION OF FUNCTIONING CARCINOID SYNDROME AND SCLERODERMA. I. CASE REPORT , 1958, The American journal of the medical sciences.
[18] J. M. Price,et al. Quantitative studies on human urinary metabolites of tryptophan as affected by isoniazid and deoxypyridoxine. , 1957, The Journal of clinical investigation.
[19] J. A. Bain,et al. Convulsant hydrazides. I. In vitro and in vivo inhibition of vitamin B6 enzymes by convulsant hydrazides. , 1957, The Journal of pharmacology and experimental therapeutics.
[20] R. Mcconnell,et al. Acute pellagra during isoniazid therapy. , 1952, Lancet.
[21] O. Frank,et al. Clinical vitaminology : methods and interpretation , 1968 .
[22] C. Scriver. Vitamin B6 deficiency and dependency in man. , 1967, American journal of diseases of children.
[23] H. Dewey,et al. The determination of tryptophan in plasma, liver, and urine. , 1967, The Journal of laboratory and clinical medicine.
[24] N. Andén,et al. An improved method for the fluorimetric determination of 5-hydroxytryptamine in tissues. , 1967, Acta physiologica Scandinavica.
[25] R. Vilter. THE VITAMIN B6--HYDRAZIDE RELATIONSHIP. , 1964, Vitamins and hormones.
[26] P. P. Sah. Nicotinyl and Isonicotinyl Hydrazones of Pyridoxal , 1954 .